Portfolio company
BlueWhale Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops cell-derived nanoparticle technology to activate and expand immune cells for cell therapy manufacturers and clinical researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Transforming cells into cures
This company develops a cellular engineering platform to design and optimize cell therapies for biopharmaceutical developers and research institutions.
Hone Bio
This company develops lipid nanoparticle targeting technology for pharmaceutical and biotechnology firms to enable precise drug delivery beyond the liver.
Appia Bio
This company develops engineered allogeneic cell therapies from hematopoietic stem cells for cancer patients.
Biothrust
This company develops bionic bioreactors for bubble-free cell cultivation to enable scalable manufacturing for pharmaceutical firms, research institutions and therapy developers.
Modulari-T Biosciences
This company develops modular immune receptors and delivery vehicles to create cell and gene therapies for patients with cancer and autoimmune diseases.
Basilard Biotech
Basilard Biotech develops gene delivery technology for cell and gene therapy manufacturers to facilitate nanomechanical engineering of cell-based treatments.
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
Cellular Origins
The company develops an automated robotic platform for cell therapy developers to manufacture and scale autologous and allogeneic therapies.
